熱門資訊> 正文

Zevra Therapeutics宣布CFO转型

2025-11-21 05:29

Zevra Therapeutics (NASDAQ:ZVRA) announced on Thursday that its CFO and Treasurer, R. LaDuane Clifton, will be stepping down from his position, effective December 31, 2025.
The company has initiated a search to identify its next CFO.

More on Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. (ZVRA) Q3 2025 Earnings Call Transcript
Zevra signals European expansion for MIPLYFFA as U.S. coverage reaches 66% following robust Q3
Zevra Therapeutics, Inc. Q3 2025 Earnings Preview
Seeking Alpha’s Quant Rating on Zevra Therapeutics, Inc.
Historical earnings data for Zevra Therapeutics, Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。